Biogen has bolstered its pipeline by licensing ex-US rights to a drug for Dravet syndrome – a rare form of epilepsy – from Stoke Therapeutics in a deal that included an upfront payment of $165 ...

‘Havana syndrome’ investigator on accusing Russia of targeting U.S. officials For the last decade, American diplomatic, law enforcement and intelligence personnel have suffered grievous ...